Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia With Open Prostatectomy: Results of a Contemporary Series
is accompanied by
Abstract
Purpose:
Surgical therapy remains the definitive treatment in patients with benign prostatic hyperplasia sequelae. Many patients with a markedly enlarged prostate are often not amenable to minimally invasive therapies. In these patients open prostatectomy is a preferred treatment. Most studies of this procedure are quite dated. Therefore, we describe the clinical results and complications of open prostatectomy performed in a modern setting using serum prostate specific antigen, the American Urological Association symptom index and quality of life scores to determine outcomes.
Materials and Methods:
We performed a prospective study in 56 patients who underwent open prostatectomy at our institution. Patients were evaluated by history and physical examination, American Urological Association symptom index, quality of life forms, prostate specific antigen, transrectal ultrasound and post-void urine volume.
Results:
Patients were followed up to 11 years postoperatively (mean 39.2 months). Of the patients 80.3% presented in acute urinary retention while on medical therapy. Baseline American Urological Association symptom index decreased from a mean ± SD of 18.5 ± 1.9 to 4 ± 1.7 within 1 month. Similarly the quality of life score was 3.1 ± 0.5 preoperatively, which decreased to 0.6 ± 0.5 postoperatively. These improvements were maintained throughout followup. The most common complication was blood loss requiring transfusion in approximately 36% of cases. Three patients had urethral strictures and 3 had bladder neck contractures that required dilation. Baseline average prostate specific antigen was 13.34 ± 1.70 ng/dl, which stabilized at less than 1 ng/dl postoperatively.
Conclusions:
Open prostatectomy may be curative in a select population of men with a large prostatic burden. To our knowledge this is the first study to demonstrate durable improvements in American Urological Association symptom index, quality of life score and prostate specific antigen along with a rare need for any further treatment after open prostatectomy.
References
- 1 : Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997: For the Patient Outcomes Research Team for Prostatic Diseases. J Urol2000; 164: 1212. Link, Google Scholar
- 2 :
Benign prostatic hyperplasia . In: Adult and Pediatric Urology. Edited by . Philadelphia: Lippincott Williams & Wilkins2002: 1401. Google Scholar - 3 : Management of symptomatic BPH in the US: who is treated and how?. Eur Urol, suppl.1999; 36: 7. Google Scholar
- 4 : Complications of Open Prostatectomy. Philadelphia: W. B. Saunders Co2001: 399. Google Scholar
- 5 : The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992–2002). BJU Int2005; 96: 1045. Google Scholar
- 6 : Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology2002; 60: 623. Google Scholar
- 7 : New diagnostic and treatment guidelines for benign prostatic hyperplasia: Potential impact in the United States. Arch Intern Med1995; 155: 477. Crossref, Medline, Google Scholar
- 8 : Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Urol2003; 44: 695. Google Scholar
- 9 : Low suprapubic prostatectomy: comparison of results with a standard operation in two comparable groups of 142 patients. J Urol1963; 90: 301. Abstract, Google Scholar
- 10 : An aid for hemostasis in open prostatectomy: capsular plication. J Urol1982; 127: 448. Abstract, Google Scholar
- 11 : The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol1997; 157: 10. Link, Google Scholar
- 12 : The outcome of suprapubic prostatectomy: a contemporary series in the developing world. Urology1995; 46: 40. Google Scholar
- 13 : Suprapubic prostatectomy The removable purse string: a continuing comparative analysis of 300 consecutive cases. J Urol1978; 120: 702. Abstract, Google Scholar
- 14 : Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol2004; 18: 189. Google Scholar
- 15 : Holmium laser enucleation of prostate for patients in urinary retention. Urology2005; 66: 789. Google Scholar
- 16 : Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: a randomized prospective trial of 120 patients. J Urol2002; 168: 1465. Link, Google Scholar
- 17 : Benign Prostatic Hyperplasia: Diagnosis and Treatment. Rockville: United States Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, xvi1994: 225. Google Scholar
- 18 : Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med1989; 320: 1120. Crossref, Medline, Google Scholar
- 19 : The management of men with acute urinary retention. Br J Urol1998; 81: 712. Google Scholar
- 20 : Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data. J Urol2002; 168: 1661. Google Scholar
Department of Urology, Feinberg School of Medicine, Northwestern University Chicago, Illinois
